Paolo Barone
#148,066
Most Influential Person Now
Italian neurologist
Paolo Barone's AcademicInfluence.com Rankings
Paolo Baronemedical Degrees
Medical
#2815
World Rank
#3254
Historical Rank
Neurology
#263
World Rank
#343
Historical Rank
Paolo Baronephilosophy Degrees
Philosophy
#8051
World Rank
#11359
Historical Rank
Logic
#5084
World Rank
#6446
Historical Rank
Download Badge
Medical Philosophy
Paolo Barone's Degrees
- Doctorate Medicine University of Milan
Why Is Paolo Barone Influential?
(Suggest an Edit or Addition)Paolo Barone's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease (2009) (1167)
- The Parkinson Progression Marker Initiative (PPMI) (2011) (1159)
- International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study (2006) (912)
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study (2007) (819)
- Depression rating scales in Parkinson's disease: Critique and recommendations (2007) (616)
- Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients (2007) (511)
- Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease (2012) (474)
- Mild cognitive impairment in Parkinson disease (2010) (443)
- Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2010) (443)
- Cognitive contributions to gait and falls: Evidence and implications (2013) (410)
- The natural history of multiple system atrophy: a prospective European cohort study (2013) (376)
- MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. (2008) (344)
- Freezing of gait and executive functions in patients with Parkinson's disease (2008) (302)
- Parkin mutations are frequent in patients with isolated early-onset parkinsonism. (2003) (301)
- Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease (2012) (271)
- Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism (2013) (264)
- Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease (2006) (242)
- Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. (2008) (235)
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort (2018) (234)
- Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. (2012) (227)
- Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease (2015) (223)
- Normative data for the Montreal Cognitive Assessment in an Italian population sample (2015) (223)
- Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry (2010) (212)
- Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. (1986) (205)
- The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life (2012) (202)
- Red flags for multiple system atrophy (2008) (198)
- Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. (2006) (197)
- Apoptotic mechanisms in mutant LRRK2-mediated cell death. (2007) (193)
- Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians (2005) (190)
- Neurotransmission in Parkinson’s disease: beyond dopamine (2010) (170)
- The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients (2013) (154)
- The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals (2017) (153)
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial (2013) (149)
- The relevance of gender in Parkinson’s disease: a review (2017) (148)
- The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand (1988) (147)
- Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease (2014) (147)
- Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study (2009) (141)
- Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease (2011) (140)
- Clinical and neurological abnormalities in adult celiac disease (2003) (137)
- The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. (2009) (128)
- Cognitive impairment in nondemented Parkinson's disease (2011) (128)
- The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration (2005) (127)
- Future thinking in Parkinson's disease: An executive function? (2012) (122)
- Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study (2013) (121)
- Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) (2006) (112)
- MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. (2006) (111)
- Unawareness of dyskinesias in Parkinson's and Huntington's diseases (2001) (111)
- Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. (2009) (111)
- Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐Analysis (2019) (110)
- Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study. (2015) (108)
- Early DEtection of wEaring off in Parkinson disease: the DEEP study. (2014) (108)
- Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait (2012) (106)
- Pergolide monotherapy in the treatment of early PD (1999) (104)
- Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (2013) (103)
- Health‐related quality of life in multiple system atrophy (2006) (101)
- Hearing impairment in Parkinson's disease: Expanding the nonmotor phenotype (2012) (101)
- Randomized study of sertraline and low‐dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life (2006) (101)
- Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease (2011) (100)
- Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients. (2015) (98)
- Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients (2012) (98)
- PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family (2014) (98)
- ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease (2017) (97)
- Diagnosis and management of Parkinson's disease dementia (2008) (97)
- Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia (2009) (93)
- Costs of illness and care in Parkinson's Disease: An evaluation in six countries (2011) (92)
- Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features (1999) (92)
- Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease (2010) (89)
- D-1 dopamine receptor changes after striatal quinolinic acid lesion. (1987) (88)
- Ropinirole as a Treatment of Restless Legs Syndrome in Patients on Chronic Hemodialysis: An Open Randomized Crossover Trial Versus Levodopa Sustained Release (2004) (88)
- Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease (2008) (88)
- Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). (2011) (88)
- Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. (2012) (87)
- A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations (2007) (86)
- Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression (2011) (85)
- Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. (1999) (84)
- Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease (2009) (84)
- Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. (2019) (82)
- How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. (2007) (81)
- Extended-release pramipexole in early Parkinson disease (2011) (80)
- The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT (2001) (80)
- Apathy in Parkinson’s Disease: Diagnosis, Neuropsychological Correlates, Pathophysiology and Treatment (2013) (78)
- PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum (2008) (77)
- Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment (2016) (76)
- Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial (2015) (76)
- Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion (2011) (75)
- A two‐year follow‐up study of executive dysfunctions in Parkinsonian patients with freezing of gait at on‐state (2010) (74)
- A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients (2015) (74)
- Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study. (2011) (73)
- Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism (2011) (73)
- Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study. (2015) (72)
- Gender differences in non-motor symptoms in early, drug naïve Parkinson’s disease (2013) (72)
- Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study (2020) (71)
- Frontal dysfunction contributes to the genesis of hallucinations in non‐demented Parkinsonian patients (2005) (71)
- The non‐motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4‐year longitudinal study (2016) (70)
- Gait patterns in parkinsonian patients with or without mild cognitive impairment (2012) (70)
- Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale (2014) (70)
- Pathological gambling in Parkinson's disease. A comprehensive review. (2013) (69)
- Treatment of depressive symptoms in Parkinson’s disease (2011) (68)
- Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release (2014) (68)
- Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study (2010) (68)
- Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy (2018) (68)
- Neuropsychological correlates of theory of mind in patients with early Parkinson's disease (2012) (68)
- Perspectives on recent advances in the understanding and treatment of Parkinson’s disease (2009) (67)
- Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. (2016) (66)
- Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. (2016) (65)
- Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study (2014) (64)
- Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data (2011) (64)
- Loss of cutaneous large and small fibers in naive and l-dopa–treated PD patients (2017) (63)
- Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis (2016) (63)
- Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis (2013) (62)
- Diffusion‐weighted imaging in multiple system atrophy: A comparison between clinical subtypes (2009) (62)
- Lateral trunk flexion in Parkinson’s disease: EMG features disclose two different underlying pathophysiological mechanisms (2011) (59)
- SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data (2017) (59)
- Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. (1991) (58)
- Physical therapy in Parkinson’s disease: an open long-term rehabilitation trial (2004) (58)
- A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. (2016) (58)
- Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease (2004) (58)
- Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study (2015) (58)
- Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients. (2014) (57)
- Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study (2019) (57)
- Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients (2012) (57)
- Pisa syndrome in Parkinson’s disease: an electrophysiological and imaging study (2013) (57)
- Quantitative autoradiographic localization of D-1 dopamine receptors in the rat brain: Use of the iodinated ligand [125I]SCH 23982 (1986) (56)
- The relationship between cerebral vascular disease and parkinsonism: The VADO study. (2012) (56)
- Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson’s disease (2004) (55)
- GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort (2020) (55)
- Dopaminergic mechanisms in hemiparkinsonian monkeys (1987) (54)
- Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? (2014) (53)
- Pisa syndrome in Parkinson disease (2015) (53)
- COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features (2008) (53)
- Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors. (1986) (53)
- Acute administration of antipsychotics modulates Homer striatal gene expression differentially. (2002) (50)
- Reduced striatal [123I]FP‐CIT binding in SCA2 patients without parkinsonism (2004) (50)
- Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients (2013) (50)
- Quality of Life and Nonmotor Symptoms in Parkinson's Disease. (2017) (49)
- Presence and progression of non‐motor symptoms in relation to uric acid in de novo Parkinson's disease (2015) (49)
- Restless legs syndrome is a common feature of adult celiac disease (2010) (49)
- Dopamine D1 receptor modulation of pilocarpine-induced convulsions (1990) (48)
- Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. (2009) (48)
- Why is there motor deterioration in Parkinson’s disease during systemic infections-a hypothetical view (2015) (47)
- Impulsive-compulsive behaviors in parkin-associated Parkinson disease (2016) (47)
- The “Gender Factor” in Wearing-Off among Patients with Parkinson's Disease: A Post Hoc Analysis of DEEP Study (2015) (47)
- Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease (2013) (46)
- Perampanel in Parkinson Disease Fluctuations: A Double-Blind Randomized Trial With Placebo and Entacapone (2012) (45)
- Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease (2016) (44)
- Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease. (2017) (44)
- Resting-state brain networks in patients with Parkinson's disease and impulse control disorders (2017) (44)
- Accuracy of clinical diagnostic criteria for Friedreich's ataxia (2000) (43)
- Insulin‐like growth factor‐1 predicts cognitive functions at 2‐year follow‐up in early, drug‐naïve Parkinson's disease (2014) (43)
- The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson’s disease in Italy (2014) (43)
- Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study (2010) (43)
- Role of Pramipexole in the Management of Parkinson’s Disease (2010) (43)
- Gender and non motor fluctuations in Parkinson's disease: A prospective study. (2016) (42)
- Olfactory dysfunction in Parkinsonism caused by PINK1 mutations (2009) (42)
- Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion‐weighted MR study (2011) (42)
- Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations (2018) (42)
- Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study (2010) (42)
- Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk? (2017) (41)
- The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson’s Disease: A meta-analysis (2017) (40)
- Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease (2015) (40)
- Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias (2006) (40)
- Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study (2015) (40)
- Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease (2007) (39)
- Walking on four limbs: A systematic review of Nordic Walking in Parkinson disease. (2017) (39)
- Cognition among individuals along a spectrum of increased risk for Parkinson’s disease (2018) (38)
- Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection. (2012) (38)
- Selective D-1 dopamine receptor agonist treatment of parkinson's disease (2005) (38)
- Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests (2018) (37)
- Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates (2017) (37)
- Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: Changes in DARPP-32 phosphorylation (1994) (36)
- Clinical strategies to prevent and delay motor complications (2003) (35)
- Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. (1997) (35)
- Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. (1984) (35)
- PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts (2019) (35)
- Apathy and Related Executive Syndromes in Dementia Associated with Parkinson’s Disease and in Alzheimer’s Disease (2013) (35)
- Subclinical sensory abnormalities in unaffected PINK1 heterozygotes (2008) (34)
- Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy (2011) (34)
- Subthreshold depression and subjective cognitive complaints in Parkinson's disease (2014) (34)
- Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients (2008) (33)
- Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease (2010) (33)
- Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions (2010) (33)
- Reproductive factors and Parkinson's disease: A multicenter case–control study (2011) (32)
- The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease (2017) (32)
- Adherence to anti-Parkinson drug therapy in the “REASON” sample of Italian patients with Parkinson’s disease: the linguistic validation of the Italian version of the “Morisky Medical Adherence scale-8 items” (2013) (32)
- Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? (2014) (32)
- Hallervorden‐Spatz syndrome resembling a typical Tourette syndrome (2002) (31)
- Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned (2016) (31)
- Lower serum uric acid is associated with mild cognitive impairment in early Parkinson’s disease: a 4-year follow-up study (2016) (31)
- Costs of Parkinson’s Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study (2010) (31)
- The PRIAMO study: background, methods and recruitment (2008) (31)
- Classifying Different Stages of Parkinson’s Disease Through Random Forests (2019) (31)
- Dopa‐responsive pseudo‐orthostatic tremor in parkinsonism (2007) (31)
- Clinical Presentation and Treatment of Wilson’s Disease: A Single-Centre Experience (2003) (30)
- Huntington's disease (1986) (30)
- Efficacy and Safety of Extended- Versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa–Undertreated Parkinson Disease: A Double-Blind, Randomized Trial (2012) (30)
- Clinical and genetic study of essential tremor in the Italian population (2001) (30)
- Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients. (2013) (30)
- Parkinsonism and essential tremor in a family with pseudo‐dominant inheritance of PARK2: An FP‐CIT SPECT study (2007) (29)
- Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study (2018) (29)
- Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases. (2013) (29)
- Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study (2020) (29)
- Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test (2006) (29)
- Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson’s disease (2007) (28)
- Increased bilirubin levels in de novo Parkinson's disease (2015) (27)
- Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features (2015) (27)
- DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients (2008) (27)
- Dopamine receptor agonists and depression in Parkinson's disease. (2009) (27)
- Midbrain MRI assessments in progressive supranuclear palsy subtypes (2019) (27)
- Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease (2016) (26)
- Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease (2014) (26)
- Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease. (2017) (26)
- P1.203 Immediate vs. delayed-start pramipexole in early Parkinson's disease: the PROUD study (2009) (26)
- Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease (2014) (25)
- Safinamide as an Add-On Therapy to a Stable Dose of a Single Dopamine Agonist: Results from a Randomized, Placebo-Controlled, 24-Week Multicenter Trial in Early Idiopathic Parkinson Disease (PD) Patients (MOTION Study) (P01.061) (2013) (25)
- The language profile of progressive supranuclear palsy (2019) (25)
- Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade. (1988) (25)
- CCK26–33 Degrading Activity in Brain and Nonneural Tissue: A Metalloendopeptidase (1985) (25)
- Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late‐onset cerebellar ataxia (2005) (25)
- Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease (2017) (25)
- HOMER1 Promoter Analysis in Parkinson’s Disease: Association Study with Psychotic Symptoms (2009) (24)
- Uric acid relates to dopamine transporter availability in Parkinson's disease (2015) (24)
- Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD (2015) (24)
- Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease (2013) (24)
- The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease. (2014) (24)
- Prophylaxis of Migraine Attacks With a Calcium‐Channel Blocker: Flunarizine Versus Methysergide (1986) (24)
- Motor, cognitive and behavioral differences in MDS PSP phenotypes (2019) (23)
- The GH–IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin‐like growth factors and clinical features (2010) (23)
- Multiple system atrophy is associated with changes in peripheral insulin‐like growth factor system (2010) (23)
- Mutational analysis of parkin gene by denaturing high-performance liquid chromatography (DHPLC) in essential tremor. (2004) (23)
- Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease (2006) (23)
- Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease. (2016) (23)
- Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease (2016) (23)
- Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait (2015) (22)
- Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease (2012) (22)
- Dopamine agonist-based strategies in the treatment of Parkinson’s disease (2008) (22)
- Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2) (2002) (22)
- Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards. (2015) (22)
- MDS PSP criteria in real‐life clinical setting: Motor and cognitive characterization of subtypes (2018) (22)
- Caffeine consumption and the 4-year progression of de novo Parkinson's disease. (2016) (22)
- Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) (2016) (21)
- Cognitive correlates of "pure apathy" in Parkinson's disease. (2018) (21)
- Quitting smoking: an early non-motor feature of Parkinson's disease? (2015) (21)
- White matter changes and the development of motor phenotypes in de novo Parkinson's Disease (2016) (21)
- Validation of the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) (2014) (20)
- The Possible Clinical Predictors of Fatigue in Parkinson's Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project (2011) (20)
- Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale (2017) (20)
- Possible gluten sensitivity in multiple system atrophy (2002) (20)
- Impaired transmethylation potential in Parkinson's disease patients treated with l-Dopa (2010) (20)
- Dopaminergic regulation of epileptic activity (1992) (20)
- Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade. (1987) (20)
- Short‐term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross‐over trial (2007) (20)
- Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy. (2014) (20)
- Bisphenol A glucuronidation in patients with Parkinson's disease (2017) (20)
- Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease (2020) (19)
- Machine Learning Approaches in Parkinson's Disease. (2021) (19)
- Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study (2012) (19)
- Blood pressure control in pregnant rabbits: norepinephrine and prostaglandin interactions. (1984) (18)
- Brain stem cystic astrocytoma presenting with “pure” parkinsonism (1999) (18)
- Interoceptive processing deficit: A behavioral marker for subtyping Parkinson's disease. (2018) (18)
- Carbamazepine lowering effect on CSF somatostatin‐like immunoreactivity in temporal lobe epileptics (1986) (18)
- Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study. (2013) (18)
- A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy. (2020) (18)
- Observational study of sleep-related disorders in Italian patients with Parkinson’s disease: usefulness of the Italian version of Parkinson’s disease sleep scale (2012) (18)
- Evolution of neuropsychological profile in motor subtypes of multiple system atrophy. (2019) (18)
- Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (17)
- Priming as a model of behavioural sensitization. (1992) (17)
- Sleep Disorders and Cognitive Dysfunctions in Parkinson’s Disease: A Meta-Analytic Study (2021) (17)
- Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? (2020) (17)
- Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease (2020) (17)
- Essential tremor is not associated with α‐synuclein gene haplotypes (2003) (17)
- The Impact of Covid-19 Lockdown on Stroke Admissions and Treatments in Campania (2020) (16)
- Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia (2020) (16)
- Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT (2008) (16)
- Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. (2006) (16)
- Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies (2016) (16)
- The FRAGAMP study: environmental and genetic factors in Parkinson’s disease, methods and clinical features (2010) (15)
- Early Ataxia and Subsequent Parkinsonism: PLA2G6 Mutations Cause a Continuum Rather Than Three Discrete Phenotypes (2017) (15)
- Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK‐2 (2009) (15)
- The closing-in phenomenon in Parkinson's disease. (2015) (15)
- Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
- Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
- Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders (2012) (15)
- Comparing postural instability and gait disorder and akinetic‐rigid subtyping of Parkinson disease and their stability over time (2019) (15)
- D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients. (1986) (15)
- Abnormal sexuality in Parkinson's disease: fact or fancy? (2016) (15)
- How does smoking affect olfaction in Parkinson's disease? (2014) (15)
- The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease (2020) (14)
- Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation (2017) (14)
- Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson’s disease (2021) (14)
- Head trauma and Parkinson’s disease: results from an Italian case-control study (2017) (14)
- The Parkinson’s Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals (2017) (14)
- Essential tremor is not associated with alpha-synuclein gene haplotypes. (2003) (14)
- A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study (2019) (14)
- CSF somatostatin immunoreactivity and GH plasma levels in Alzheimer's disease (1984) (14)
- Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania. (2014) (14)
- Exercise dependence induced by pramipexole in Parkinson's Disease—A Case Report (2010) (14)
- Serum miR-30c-5p is a potential biomarker for multiple system atrophy (2019) (13)
- Cognitive and affective theory of mind in patients with essential tremor (2013) (13)
- Neurology and the COVID-19 emergency (2020) (13)
- RNA analysis of consensus sequence splicing mutations: implications for the diagnosis of Wilson disease. (2009) (13)
- Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single‐Blinded Study (2016) (13)
- Screening for Aphasia in NeuroDegeneration for the Diagnosis of Patients with Primary Progressive Aphasia: Clinical Validity and Psychometric Properties (2018) (13)
- Neural bases of impulse control disorders in Parkinson’s disease: A systematic review and an ALE meta-analysis (2019) (13)
- Restless legs syndrome is a common feature of adult celiac disease Movement Disorders 2010:25; 877 – 881 (2010) (13)
- The PRIAMO study: active sexual life is associated with better motor and non‐motor outcomes in men with early Parkinson's disease (2019) (13)
- Severe Dyskinesia After Administration of SARS‐CoV2 mRNA Vaccine in Parkinson's Disease (2021) (13)
- No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients (2001) (13)
- Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages (2021) (12)
- Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease (2013) (12)
- Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.. Dec 15;23(16):2370-6.PMID: 18816803 (2008) (12)
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis (2021) (12)
- Association study between the LINGO1 gene and Parkinson's disease in the Italian population. (2011) (12)
- Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family (2014) (12)
- Nitric oxide‐haemoglobin interaction: A new biochemical hypothesis for signal changes in fMRI (1997) (12)
- Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). (2019) (12)
- Impact of COVID-19 on neurological patients attending a botulinum toxin service (2020) (12)
- Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations (2017) (11)
- Milestones in Tremor Research: 10 Years Later (2022) (11)
- Cholecystokinin octapeptide analogues stable to brain proteolysis (1985) (11)
- Uterine and peripheral blood concentrations of vasodilator prostaglandins in conscious pregnant rabbits. (1982) (11)
- Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline (1983) (11)
- Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning (2020) (11)
- Paroxysmal dystonia in Behçet's disease (1999) (11)
- Subcortical atrophy and perfusion patterns in Parkinson disease and multiple system atrophy. (2020) (10)
- Progressive Supranuclear Palsy–Like Phenotype in a GBA E326K Mutation Carrier (2017) (10)
- Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia (2001) (9)
- Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients. (2009) (9)
- The arginine growth hormone stimulation test in bradykinetic‐rigid parkinsonisms (2008) (9)
- Association of Essential Tremor With Novel Risk Loci (2022) (9)
- Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study. (2020) (9)
- Effect of a radiographic contrast agent on renal function in the rat. Comparison with equiosmolar mannitol. (1986) (9)
- Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease (2016) (9)
- Cholecystokinin‐mediated Synaptic Function and the Treatment of Neuropsychiatric Disease (1985) (9)
- From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations. (2019) (9)
- Malabsorption is uncommon in restless legs syndrome (2011) (9)
- Sex Differences in Parkinson’s Disease: From Bench to Bedside (2022) (9)
- Neuropsychological profile of hearing-impaired patients and the effect of hearing aid on cognitive functions: an exploratory study (2021) (9)
- Effects of gender on cognitive and behavioral manifestations in multiple system atrophy (2020) (9)
- Pure unilateral hyperhidrosis after pontine infarct (2003) (8)
- Laparoscopic harvest of an omental flap to reconstruct an infected sternotomy wound. (2006) (8)
- Patients with Parkinson’s disease and scans with (predominant) ipsilateral dopaminergic deficit (2013) (8)
- Wine drinking and essential tremor: A possible protective role (2011) (8)
- The role of disease duration and severity on novel clinical subtypes of Parkinson disease. (2020) (8)
- Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy (2019) (8)
- Identification by [ 99 mTc ] ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy , in comparison with Parkinson ’ s disease (2007) (8)
- Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy (2015) (7)
- The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017 (2021) (7)
- Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming (2005) (7)
- Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians (2020) (7)
- Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study (2015) (7)
- Linkage exclusion in Italian families with hereditary essential tremor (2011) (7)
- Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy (2020) (7)
- Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease (2022) (7)
- Non-Motor Correlates of Smoking Habits in de Novo Parkinson's Disease. (2015) (7)
- Spread of dystonia in patients with idiopathic adult‐onset laryngeal dystonia (2018) (7)
- Mild Cognitive Impairment Subtypes Are Associated With Peculiar Gait Patterns in Parkinson’s Disease (2022) (7)
- Bilateral facial palsy after COVID-19 vaccination (2022) (6)
- Early MRI findings in acquired hepatocerebral degeneration (2013) (6)
- Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsy (2021) (6)
- Parkinson’s disease management and impulse control disorders: current state and future perspectives (2019) (6)
- Pallidal stimulation in atypical pantothenate kinase‐associated neurodegeneration: Six‐year follow‐up (2014) (6)
- Role of D1 and D2 Dopamine Receptors in Pilocarpine-Induced Seizures (1991) (6)
- Nonmotor symptoms in Parkinson's disease: classification and management (2015) (6)
- Season of birth and Parkinson’s disease: possible relationship? (2015) (6)
- Progression of Parkinson’s Disease and Unmet Needs in Mid- to Late-stage Patients (2015) (6)
- Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding (2013) (6)
- The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease (2021) (6)
- Abnormal eating behaviors in progressive supranuclear palsy (2013) (6)
- Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? (1987) (6)
- Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease (2019) (6)
- Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease (2021) (5)
- Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study (2021) (5)
- The Spectrum of PRRT2-Associated Disorders: Update on Clinical Features and Pathophysiology (2021) (5)
- Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy (2021) (5)
- Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes. (2020) (5)
- The Italian tremor Network (TITAN): rationale, design and preliminary findings (2022) (5)
- Impulse control disorders and cognitive dysfunctions in patients with Parkinson’s disease (2013) (5)
- The “eye of the tiger” sign in pure akinesia with gait freezing (2011) (5)
- Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease (2017) (5)
- Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry (2020) (5)
- Erratum to: Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale (2014) (5)
- Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease (2015) (5)
- Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables (2022) (5)
- Gait Analysis in Progressive Supranuclear Palsy Phenotypes (2021) (5)
- Gender differences in non-motor symptoms in early, drug naïve Parkinson'/INS;s disease (2013) (5)
- Are granular osmiophilic material deposits an epiphenomenon in CADASIL? (2015) (5)
- Neuroimaging in idiopathic adult-onset focal dystonia (2021) (4)
- Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study (2019) (4)
- Validation of the Italian version of the PSP Quality of Life questionnaire (2019) (4)
- Essential tremor plus rest tremor: current concepts and controversies (2022) (4)
- Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case report (2021) (4)
- Attachment styles, identification of feelings and psychiatric symptoms in functional neurological disorders. (2021) (4)
- Dopamine mediated responses in 6-hydroxydopamine lesioned rats involve changes of the signal transduction. (1995) (4)
- Cutaneous sensory and autonomic denervation in progressive supranuclear palsy (2021) (4)
- A Novel Phenotype Associated with CaSR‐Related Familial Brain Calcifications (2020) (4)
- APP‐Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes (2020) (4)
- Theory of mind and joint action in Parkinson’s disease (2018) (4)
- Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects (2016) (4)
- Headache Patients: Different Responses Induced by Naloxone During Work-Test (1982) (4)
- Ping-pong gaze: Sherrington would not have done it better. (2014) (4)
- Letter by Moccia et al regarding article, "Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism". (2014) (3)
- Drug induced oromandibular dystonia: a case related to prolonged use of cetirizine. (2014) (3)
- Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy (2019) (3)
- Safinamide is effective as add-on treatment in both early and Advanced PD (2013) (3)
- Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study (2022) (3)
- Comment on Szewczyk-Krolikowski et al.: the influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. (2014) (3)
- Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages. (2013) (3)
- Plasma prolactin response to sodium valproate in epileptic patients (1984) (3)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site. (2021) (3)
- Prevalence of heterozygous mutations in Niemann-Pick type C genes in a cohort of progressive supranuclear palsy. (2020) (3)
- Reliability and validity of the novel Italian version of the 14-item Resilience Scale (RS-14) in adults (2021) (3)
- Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism (2013) (2)
- Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort (2022) (2)
- PRODEST study: depressive symptoms in Parkinson's disease (2007) (2)
- The language profile in multiple system atrophy: an exploratory study (2021) (2)
- P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease (2009) (2)
- On the relationship between side of onset and cognition in Parkinson disease. (2015) (2)
- Interplay between gait and neuropsychiatric symptoms in Parkinson’s Disease (2022) (2)
- Imaging of the progression of nigrostriatal deficit in early-onset parkin disease with [123I]FP-CIT SPECT (2006) (2)
- Affective theory of mind in patients with Parkinson's disease: Comment (2014) (2)
- Inhibition of septal hyperreactivity by testosterone and its reversion by an estrogen antagonist in weanling female rats (1983) (2)
- Interaction between affect and executive functions in Parkinson’s disease (2010) (2)
- Cystic biliary anomaly in a newborn with features of choledochal cyst and cystic biliary atresia (2021) (2)
- Theory of Mind in multiple system atrophy: comparison with Parkinson’s disease and healthy subjects (2020) (2)
- Metabolomics in Parkinson's disease. (2021) (2)
- Parkinsonism in diseases predominantly presenting with dystonia. (2019) (2)
- The "zig-zag" sign in Progressive Supranuclear Palsy. (2020) (2)
- Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study. (2021) (2)
- Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat (2004) (2)
- Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19 (2020) (1)
- Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088) (2012) (1)
- Prodest - Depressive symptoms in Parkinson's disease: Demographic data (2007) (1)
- Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait (2009) (1)
- Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. Apr;256(4):632-8. 370301 (2009) (1)
- Sustained efficacy and tolerability of pramipexole extended-release as adjunctive treatment in advanced Parkinson's disease (2010) (1)
- Erratum to: Validation of the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) (2015) (1)
- Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (1)
- Corrigendum to “Early detection of wearing off in Parkinson disease: The DEEP study” [Parkinsonism Relat Disorder 20 (2014) 204–211] (2015) (1)
- P6.18 Pisa Syndrome in Parkinson's disease: EMG features disclose two different underlying pathophysiological mechanisms (2011) (1)
- Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis (2022) (1)
- More methods for managing shoulder dystocia. (1992) (1)
- Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic (2021) (1)
- Parkinson’s disease and sleep (2004) (1)
- International validation study of the first comprehensive unified Nonmotor Symptoms Scale (NMSS) for Parkinson's disease (PD) (2006) (1)
- Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP‐RS and vPSP (2021) (1)
- Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. (2014) (1)
- Cortical thickness in Parkinsonians with impulse control disorders: A comment (2015) (1)
- Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study (2013) (1)
- Paradoxical response to apomorphine in a case of atypical parkinsonism (2002) (1)
- D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. (1989) (1)
- Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease (2022) (1)
- Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease (2022) (1)
- Bipolar Disorder and Parkinson's Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study (2021) (1)
- Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register (2022) (1)
- Instagram for Measuring Tremor: Who Holds the Camera? (2022) (1)
- Oxygen-ozone therapy in a multidisciplinary day surgery: Design and applications (2017) (1)
- P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage (2009) (1)
- Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome (2022) (1)
- Subject Index Vol. 59, 2009 (2009) (1)
- A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort. (2022) (1)
- Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists (2020) (1)
- 5th International Conference on Neurology and Epidemiology. Gold Coast, Australia, November 18-20, 2015: Abstracts (2015) (1)
- Gait patterns and cognition in Parkinson's disease (2012) (0)
- A SCREENING FOR APHASIA IN NEURODEGENERATION FOR THE DIAGNOSIS OF PATIENTS WITH PRIMARY PROGRESSIVE APHASIA. CLINICAL VALIDITY AND PSYCHOMETRIC PROPERTIES VALIDITY OF SAND IN PRIMARY PROGRESSIVE APHASIA (2019) (0)
- Late Breaking Posters (2003) (0)
- 1.108 DEEP STUDY: A LARGE EPIDEMIOLOGICAL SURVEY ABOUT WEARING OFF IN PARKINSON DISEASE (2012) (0)
- Gender differences in microRNA expression in levodopa-naive PD patients. (2023) (0)
- Parkinsonism Carers Quality of Life--Italian Version (2020) (0)
- 2.263 PATIENT-REPORTED CONVENIENCE OF ONCE-DAILY VS TID DOSING DURING LONG-TERM STUDIES OF PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE (2012) (0)
- Risks of Inappropriate Secretion of Antidiuretic Hormone in Multiple System Atrophy (2011) (0)
- Contents Vol. 7, 2010 (2010) (0)
- Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study. (2022) (0)
- Off-label DaT-SCAN use: a single-center, real-world study. (2023) (0)
- PINK1 mutations cause typical late-onset Parkinson's disease as well as early-onset Parkinsonism. (2006) (0)
- V36 Health-related quality of life in patients with Parkinson’s disease in Europe: Multicenter study of the EuroPA Study Group (2011) (0)
- Restless Legs syndrome in adult Celiac disease (2009) (0)
- Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers (2015) (0)
- Impulsive-compulsive behaviors in Parkin-associated Parkinson's disease: a case-control study (2016) (0)
- Sustained off-time decrease in patients using pramipexole extended-release as adjunctive treatment in advanced Parkinson's disease (2010) (0)
- Machine learning can predict mild cognitive impairment in Parkinson's disease (2022) (0)
- Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. (1995) (0)
- Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study (2021) (0)
- Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease (2016) (0)
- Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy. (2023) (0)
- Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings (2022) (0)
- Non-Motor Symptoms Questionnaire (2021) (0)
- Handbook of Atypical Parkinsonism: Parkinson's disease and the spectrum of Lewy body disease (2011) (0)
- Higher Health Service Costs Associated With Delayed Diagnosis of Functional Neurological Disorder. (2022) (0)
- Design of a randomized, placebo-controlled trial of pramipexole in patients with Parkinson's disease and depressive symptoms (2008) (0)
- The role for fragile x premutation in essential tremor and spinocerebellar ataxia: findings from two cohorts of Italian patients. (2004) (0)
- Serum miR-30c-5p is a potential biomarker for multiple system atrophy (2019) (0)
- Hemi‐restless legs syndrome induced by clebopride (2012) (0)
- Future thinking in Parkinson's disease: The contribution of executive functions (2011) (0)
- A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study (2019) (0)
- 16 Gait features in parkinsonian patients with or without mild cognitive impairment (2012) (0)
- A novel phenotype in an Italian family with a rare progranulin mutation (2022) (0)
- The accuracy of the arginine growth hormone test in Parkinsonism (2008) (0)
- Differential neuropsychological profiles in parkinsonian patients with or without vascular lesions (2011) (0)
- GABAergic, GDNF and Sphingolipid Pathways Are Potentially Druggable Targets in Neurodegenerative Diseases: Lumping Is Better than Splitting (2022) (0)
- [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists]. (1988) (0)
- Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates. (2023) (0)
- An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population (2012) (0)
- Comparison of duplex ultrasonography with digital substraction angiography in the assessment of symptomatic carotid artery stenosis (2014) (0)
- Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management. (2023) (0)
- Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009 (2009) (0)
- Opsoclonus-Myoclonus Syndrome and Exaggerated Startle Response Associated With Small-Cell Lung Cancer (2011) (0)
- 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE (2012) (0)
- Health-related quality of life and pharmacotherapy in Parkinson's disease: results of a multi-country study of the EuroPA Study Group (2009) (0)
- 47. Early sensory and autonomic involvement in drug-naive Parkinson (2016) (0)
- Progressive Supranuclear Palsy Quality of Life Scale--Italian Version (2020) (0)
- Childhood‐onset dystonia with cerebellar signs: expanding the spectrum of GNAL mutations (2020) (0)
- Contents Vol. 45, 2015 (2015) (0)
- International validation of the first non-motor questionnaire (NMSQuest) and scale (NMSS) for Parkinson's disease (2007) (0)
- PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family (2014) (0)
- Changes in transcription activity in the rat brain following the acute administration of typical and atypical neuroleptics (1999) (0)
- The contribution of the Italian residents in neurology to the COVID-19 crisis: admirable generosity but neurological training remains their priority (2021) (0)
- D 1 but not d 2 dopamine receptor stimulation reduces the threshold for pilocarpine induced epileptic activity in rats (1988) (0)
- Postsynaptic density protein gene expression after typical or atypical antipsychotics administration (2000) (0)
- ESRA19-0125 Pericapsular nerve group (PENG) block in the management of postoperative pain: case report of reprise total prostheses of ANCA (2019) (0)
- Comparisons among responses to pramipexole extended-release as adjunctive treatment in Japanese and non-Japanese studies of advanced Parkinson's disease (2010) (0)
- 1.134 Pain and Parkinson's disease: A case-control Italian multicenter study (2007) (0)
- Evolution of mild cognitive impairment in Parkinson disease (2014) (0)
- Sex differences in neuromuscular disorders (2023) (0)
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Pet Study Using [ 11C ] PBR28 and Machine Learning Enhanced Analysis (2021) (0)
- PET evaluation of dopamine transporters in early and late onset patients with Parkinson's disease (2001) (0)
- Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study. (2022) (0)
- Intensive rater training to standardize cognitive assessment : a study to assess the effect of rasagiline on mild cognitive impairment in Parkinson ’ s disease patients (2014) (0)
- Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status (2022) (0)
- Correction to: Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT (2021) (0)
- Identification of a Gait Pattern for Detecting Mild Cognitive Impairment in Parkinson’s Disease (2023) (0)
- Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment (2010) (0)
- Data-driven clustering of combined Functional Motor Disorders based on the Italian registry (2022) (0)
- Energy expenditure, body composition and dietary habits in progressive supranuclear palsy (2021) (0)
- Temporal muscle thickness as predictor of survival in patients with amyotrophic lateral sclerosis (2021) (0)
- Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease (2021) (0)
- Magnetic resonance T1w/T2w ratio in multiple system atrophy: A combined study with voxel-based morphometry (2021) (0)
- Short communication Acute administration of antipsychotics modulates Homer striatal gene (2002) (0)
- Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study (2015) (0)
- P102 A long-term study on the safety of rivastigmine capsule and patch in mild to moderate Parkinson’s disease dementia (2011) (0)
- Frequency and clinical features of GBA mutations in Italian patients with Parkinson disease (2015) (0)
- Non-motor symptoms (NMS)in parkinsonism: preliminary results of the PRIAMO(Parkinson and non-motor symptoms)study (2006) (0)
- Author response for "Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsy" (2021) (0)
- Is arginine test a reliable tool for differential diagnosis of multiple system atrophy? (2010) (0)
- Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study (2022) (0)
- PERICAPSULAR NERVE GROUP (PENG) BLOCK IN THE MANAGEMENT OF POSTOPERATIVE PAIN: CASE REPORT OF REPRISE TOTAL PROSTHESES OF ANCA (2019) (0)
- P2.153 Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease (2009) (0)
- Corticobasal Degeneration Reveals Its Signature by Tau Strains (2020) (0)
- DOPAMINE D-1 RECEPTOR-MEDIATED RESPONSES IN 6-OHDA LESIONED RATS: SENSITIZATION DEVELOPMENT INVOLVES TRANSDUCTIONAL PATHWAYS (1993) (0)
- Subject Index Vol. 7, 2010 (2010) (0)
- “Response to Apomorphine in early Parkinson’s disease”. (2004) (0)
- D 1 and d 2 dopamine system interactions in the 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine lesioned monkey (1986) (0)
- Teaching Video NeuroImages: Finger clonus (2016) (0)
- Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease (2015) (0)
- Forum Report The 4th International Expert Meeting on the Treatment of Parkinson's Disease パーキンソン病におけるうつ病--病態生理,診断および治療戦略 (2010) (0)
- Theory of mind and joint action in Parkinson’s disease (2018) (0)
- 84. Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and freezing of gait (2015) (0)
- OPIOID MECHANISMS, AMPHETAMINE SENSITIZATION, AND ANIMAL MODELS OF INGESTIVE DISORDERS (1996) (0)
- Contents Vol. 59, 2009 (2009) (0)
- Does an association between cigarette smoking and Parkinson's Disease-related psychosis exist? Insights from a large non-demented cohort (2021) (0)
- Impulsivity andcompulsivity in drug-naïve patients with Parkinson's disease (2011) (0)
- Parkinson's Progression Markers Initiative brain autopsy program. (2022) (0)
- The use of smell identification test in Parkinson's disease in Italy: Preliminary data (2011) (0)
- 1.8.3 NON MOTOR SYMPTOMS IN PD: IMPACT ON QUALITY OF LIFE AND MEDICAL TREATMENT (2012) (0)
- ASSESSMENT OF MOTOR SYMPTOMS IN A LONG-TERM SAFETY STUDY OF RIVASTIGMINE CAPSULES AND PATCH IN PATIENTS WITH DEMENTIA ASSOCIATED WITH PARKINSON'S DISEASE (2011) (0)
- 1.167 PRODEST – Depressive symptoms in Parkinson's disease: Pattern across scales (2007) (0)
- Early cues to detect atypical panthothenate kinase-associated neurodegeneration. (2015) (0)
- Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation (2017) (0)
- A SIMULATION TOOL TO PLAN DAILY NURSE REQUIREMENTS (0)
- MEDIAL CUTANEOUS NERVE OF THE CALF NEUROPATHY DUE TO PAINTBALL TRAUMA. (2021) (0)
- Anterior lumbosacral polyradiculoneuropathy following intrathecal methotrexate administration: a case report and literature update (2022) (0)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site, data from the Italian dystonia registry (2021) (0)
- PSP Look-Alike due to CADASIL (2017) (0)
- Pathology of Vessels Supplying the Brain in Patients with Parkinson’s Disease (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Barone?
Paolo Barone is affiliated with the following schools:
